Intravenous nitrates for pharmacological stimulation during head-up tilt testing in patients with suspected vasovagal syncope and healthy controls

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 11, 1999, Pages 1593-1598

  Aerts, Arnaud J J ^a   Dendale, Paul ^d   Daniels, Cathy ^b   Meyvisch, Paul ^c   Kaufman, Leonard ^c   Strobel, Gunnar ^b   Block, Pierre ^b  

^a Zuyderland Medical Centre   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d NONE

Author keywords

Nitrates; Tilt table testing; Vasovagal syncope

Indexed keywords

ISOSORBIDE DINITRATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHARMACOLOGICAL STIMULATION; RECEIVER OPERATING CHARACTERISTIC; SYNCOPE; TILT TABLE TEST;

EID: 0032727356     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00377.x     Document Type: Article

References (28)

1. 1. Calkins H, Byrne M, El-Atassi R, et al. The economic burden of unrecognized vasodepressor syncope. Am J Med 1993; 95:473-479.
2. 2. Ruiz GA, Peralta A, Gonzales-Zuelgaray, et al. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment. Am Heart J 1995; 130:345-350.
3. 3. Driscoll DJ, Jacobsen SJ, Porter CJ, et al. Syncope in children and adolescents. J Am Coll Cardiol 1997; 29:1039-1045.
4. 4. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: A comprehensive literature review. Am J Med 1994; 97:78-88.
5. 5. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996; 28:263-275.
6. 6. Raviele A, Gasparini G, Di Pede F, et al. Usefulness of head up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990; 65:1322-1327.
7. 7. Fitzpatrick AP, Theodorakis G, Vardas P, et al. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17:125-130.
8. 8. Aerts A, Dendale P, Strobel G, et al. Sublingual nitrates during head up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133: 504-507.
9. 9. Rubin AM, Rials SJ, Marinchak RA, et al. The head up tilt table test and cardiovascular syncope. Am Heart J 1993; 125:476-482.
10. 10. Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993; 328:1117-1120.
11. 11. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J M 1989; 320: 346-351.
12. 12. Gulamhusein S, Naccarelli GV, Ko PT, et al. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med 1982; 73:700-705.
13. 13. Sra JS, Anderson AJ, Sheik SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head up tilt testing. Ann Intern Med 1991; 114:1013-1019.
14. 14. Waxman MB, Yao L, Cameron DA, et al. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons. Am J Cardiol 1989; 63:58-65.
15. 15. Calkins H, Kadish A, Sousa J, et al. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope. Am J Cardiol 1991; 67:207-209.
16. 16. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992; 19:773-779.
17. 17. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol: A non specific test. Ann Intern Med. 1991; 116:358-363.
18. 18. Weissler AM, Warren JV, Estes EH Jr, et al. Vasodepressor syncope. Factors influencing cardiac output. Circulation 1957; 15:875-882.
19. 19. Karp HR, Weissler AM, Heyman A. Vasodepressor syncope: EEG and circulatory changes. Arch Neurol 1961; 5:106-113.
20. 20. Come PC, Pitt B, Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation 1976; 54; 624-628.
21. 21. Raviele A., Gasparini G, Di Pede F, et al. Nitroglycerin infusion during upright tilt. A new test for the diagnosis of vasovagal syncope. Am Heart J 1993; 127:103-111.
22. 22. De Jong-deVos van Steenwijk CC, Wieling W, Johannes JM, et al. Incidence and hemodynamic characteristics of near fainting in healthy 6-to 16-year old subjects. J Am Coll Cardiol 1995; 25: 1615-1621.
23. 23. Stevens PM. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation. Am J Cardiol 1966; 17:211-218.
24. 24. Mcintosch SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994; 23:317-319.
25. 25. Lewis T: A lecture on vasovagal syncope and the carotid sinus mechanism. Br Med J 1932; 1:873.
26. 26. Lipsitz LA, Marks ER, Koestner J, et al. Reduced susceptibility to syncope during postural tilt in old age. Arch Intern Med 1989; 149:2709-2712.
27. 27. Nozzoli C, Buonomo C, Simone F. Syncopes with reference to sex and age. Funct Neurol 1990; 3:251-255.
28. 28. Sheldon R. Effects of aging on responses to isoproterenol tilt table testing in patients with syncope. Am J Cardiol 1994; 74:459-463.